Intimation on publication of newspaper advertisement pursuant to regulation 47(1) of SEBI (LODR).
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Integrated Proteins Ltd has informed BSE that it published its unaudited financial results for the quarter ended June 30, 2025 in Economic Times (English) and Navgujarat Samay (Gujarati) on August 15, 2025, as required under SEBI LODR Regulation 47(1). Total income from operations stood at Rs 2,148.67 lakhs, almost flat compared to Rs 2,149.63 lakhs in the previous quarter. Net profit after tax collapsed to just Rs 0.01 lakh from Rs 21.29 lakhs in Q4 FY25, and EPS fell to essentially zero from Rs 0.60. Separately, the company noted that 55.10 lakh convertible warrants were exercised and converted into an equal number of equity shares on August 7, 2025, resulting in equity dilution.
The filing itself is a routine compliance disclosure, but the underlying results show a sharp drop in profitability to near-zero levels, which may concern shareholders. The conversion of 55.10 lakh warrants into equity shares has also increased the share count, adding dilution risk.